08/04/2019
HPV Vaccine To Be Extended To Boys
Boys aged 12-13 in Northern Ireland will soon be offered a vaccine to help protect them against Human Papillomavirus (HPV) and other related cancers.
It comes as the Department of Health makes two significant health protection announcements today, Monday 08 April.
A better test for bowel cancer to increase uptake rates and detect more cancers earlier is also due to be rolled out. The Faecal Immunochemical Test (FIT) will replace the Faecal Occult Blood (FOB) test as the primary screening test for bowel cancer screening.
Department of Health Permanent Secretary Richard Pengelly said: "I am very pleased to be able to announce both these decisions today. The evidence is clear in both cases that very significant health protection benefits can be achieved for our citizens."
Their implementation follows confirmation of the Department's budget allocation for this year.
A high proportion of women under 25 have already taken up the opportunity to be vaccinated against the HPV virus since the programme was first introduced in 2008 and the intention is to protect boys through similar uptake rates.
This extended programme offers the opportunity to make some HPV-related diseases and cancers a thing of the past building on the success of the programme in girls. The prevalence of the main HPV cancer-causing types 16 and 18 has already been reduced by over 80%.
Commenting on the HPV announcement, Chief Medical Officer Dr Michael McBride said: "We can now look forward to a future where we can be even more confident that we will reduce cervical cancer and other HPV related cancers that affect both men and women.
"This is an effective vaccine against a particularly harmful virus. I would encourage all parents to take up this offer and ensure their boys and girls are vaccinated."
The new FIT bowel screening test will be introduced from early 2020.
Evidence has shown there is increased patient acceptability of the FIT screening test and increased uptake of screening will mean even more lives can be saved.
Every year in Northern Ireland there are around 1100 new cases of bowel cancer, with over 400 deaths. The Bowel Cancer Screening Programme aims to pick it up at an early stage, when treatment can be 90% successful.
Dr McBride added: "The existing test for bowel cancer has proved hugely valuable in detecting cancer early and it is therefore essential that people invited to participate in the Northern Ireland Bowel Screening programme from 60-74 continue to complete and return the test they receive in the post until the new test is available."
Extending the HPV vaccination programme to include adolescent boys is based on advice from the Joint Committee of Vaccination and Immunisation (JCVI) an independent panel of experts that provides advice to the four UK Health Departments.
The extension of the vaccine to boys follows the success of Northern Ireland's HPV vaccination programme for girls which started in 2008 and the HPV programme for men who have sexual relations with men (MSM), introduced in 2016.
(JG/CM)
It comes as the Department of Health makes two significant health protection announcements today, Monday 08 April.
A better test for bowel cancer to increase uptake rates and detect more cancers earlier is also due to be rolled out. The Faecal Immunochemical Test (FIT) will replace the Faecal Occult Blood (FOB) test as the primary screening test for bowel cancer screening.
Department of Health Permanent Secretary Richard Pengelly said: "I am very pleased to be able to announce both these decisions today. The evidence is clear in both cases that very significant health protection benefits can be achieved for our citizens."
Their implementation follows confirmation of the Department's budget allocation for this year.
A high proportion of women under 25 have already taken up the opportunity to be vaccinated against the HPV virus since the programme was first introduced in 2008 and the intention is to protect boys through similar uptake rates.
This extended programme offers the opportunity to make some HPV-related diseases and cancers a thing of the past building on the success of the programme in girls. The prevalence of the main HPV cancer-causing types 16 and 18 has already been reduced by over 80%.
Commenting on the HPV announcement, Chief Medical Officer Dr Michael McBride said: "We can now look forward to a future where we can be even more confident that we will reduce cervical cancer and other HPV related cancers that affect both men and women.
"This is an effective vaccine against a particularly harmful virus. I would encourage all parents to take up this offer and ensure their boys and girls are vaccinated."
The new FIT bowel screening test will be introduced from early 2020.
Evidence has shown there is increased patient acceptability of the FIT screening test and increased uptake of screening will mean even more lives can be saved.
Every year in Northern Ireland there are around 1100 new cases of bowel cancer, with over 400 deaths. The Bowel Cancer Screening Programme aims to pick it up at an early stage, when treatment can be 90% successful.
Dr McBride added: "The existing test for bowel cancer has proved hugely valuable in detecting cancer early and it is therefore essential that people invited to participate in the Northern Ireland Bowel Screening programme from 60-74 continue to complete and return the test they receive in the post until the new test is available."
Extending the HPV vaccination programme to include adolescent boys is based on advice from the Joint Committee of Vaccination and Immunisation (JCVI) an independent panel of experts that provides advice to the four UK Health Departments.
The extension of the vaccine to boys follows the success of Northern Ireland's HPV vaccination programme for girls which started in 2008 and the HPV programme for men who have sexual relations with men (MSM), introduced in 2016.
(JG/CM)
Related Northern Ireland News Stories
Click here for the latest headlines.
10 October 2023
New Era For Cervical Screening In Northern Ireland
Primary HPV testing is to be fully introduced in a major boost to Northern Ireland's Cervical Screening Programme. The Department of Health (DoH) has confirmed that they are on course for the full introduction of primary HPV testing, which is more sensitive than cytology-based screening, by December 2023.
New Era For Cervical Screening In Northern Ireland
Primary HPV testing is to be fully introduced in a major boost to Northern Ireland's Cervical Screening Programme. The Department of Health (DoH) has confirmed that they are on course for the full introduction of primary HPV testing, which is more sensitive than cytology-based screening, by December 2023.
01 February 2013
Poots Announces New Cervical Cancer Test
A test for the human papilloma virus (HPV) is to be included within the Northern Ireland cervical cancer-screening programme, the health minister has announced. Edwin Poots said the link between HPV and cervical cancer had "long been established" and the aim of the programme is to reduce the number of women who develop cervical cancer.
Poots Announces New Cervical Cancer Test
A test for the human papilloma virus (HPV) is to be included within the Northern Ireland cervical cancer-screening programme, the health minister has announced. Edwin Poots said the link between HPV and cervical cancer had "long been established" and the aim of the programme is to reduce the number of women who develop cervical cancer.
12 December 2023
Full Primary HPV Testing Introduced In NI
Full primary HPV testing has been officially introduced to the cervical screening pathway, bringing Northern Ireland into line with the rest of the UK and Republic of Ireland. Between 2016 and 2020 in NI, an average of 81 people were diagnosed with cervical cancer each year, and there were around 21 deaths from cervical cancer annually.
Full Primary HPV Testing Introduced In NI
Full primary HPV testing has been officially introduced to the cervical screening pathway, bringing Northern Ireland into line with the rest of the UK and Republic of Ireland. Between 2016 and 2020 in NI, an average of 81 people were diagnosed with cervical cancer each year, and there were around 21 deaths from cervical cancer annually.
16 September 2002
Larne test centre receives top quality award
Management and staff of the Driver & Vehicle Testing Agency’s Larne Test Centre have received a top award in recognition of their achievements from Environment Minister Dermot Nesbitt today.
Larne test centre receives top quality award
Management and staff of the Driver & Vehicle Testing Agency’s Larne Test Centre have received a top award in recognition of their achievements from Environment Minister Dermot Nesbitt today.
31 January 2013
New Cervical Screening Test Will Benefit Women
Testing for the Human Papilloma Virus (HPV) will bring real benefits to women. That was the message from the Health Minister as he announced that a test for HPV has now been incorporated within the Northern Ireland Cervical Cancer Screening Programme.
New Cervical Screening Test Will Benefit Women
Testing for the Human Papilloma Virus (HPV) will bring real benefits to women. That was the message from the Health Minister as he announced that a test for HPV has now been incorporated within the Northern Ireland Cervical Cancer Screening Programme.